These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 498417)

  • 1. Biological activities of rubidazone.
    Maral R
    Cancer Chemother Pharmacol; 1979; 2(1):31-5. PubMed ID: 498417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation and experimental antitumor activity of a new semi-synthetic antibiotic: 14-diethoxyacetoxy daunorubicin (R.P. 33 921)].
    Maral R; Ducep JB; Farge D; Ponsinet G; Reisdorf D
    C R Acad Hebd Seances Acad Sci D; 1978 Feb; 286(5):443-6. PubMed ID: 418906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline.
    Tong GL; Henry DW; Acton EM
    J Med Chem; 1979 Jan; 22(1):36-9. PubMed ID: 423181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic response to cultured human lymphoid cells to rubidazone.
    Barlogie B; Drewinko B; Benjamin RS
    J Natl Cancer Inst; 1978 Feb; 60(2):279-82. PubMed ID: 621746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin).
    Maral R; Heusse D; Lavelle F; Cueille G; Marlard M; Jacquillat C; Maral J; Auclerc MF; Weil M; Auclerc G; Bernard J
    Recent Results Cancer Res; 1980; 74():172-83. PubMed ID: 7444138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
    Zbinden G; Brändle E
    Cancer Chemother Rep; 1975; 59(4):707-15. PubMed ID: 1175165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and metabolism of rubidazone and daunorubicin in mice.
    Baurain R; Deprez-De Campeneere D; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):37-41. PubMed ID: 498418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic, antiviral, and antitumor activity of some derivatives of daunomycin (NSC-82151).
    Di Marco A; Casazza AM; Dasdia T; Giuliani F; Lenaz L; Necco A; Soranzo C
    Cancer Chemother Rep; 1973; 57(3):269-74. PubMed ID: 4751254
    [No Abstract]   [Full Text] [Related]  

  • 11. Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents.
    Lown JW; Chen HH; Plambeck JA; Acton EM
    Biochem Pharmacol; 1979 Sep; 28(17):2563-8. PubMed ID: 229856
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of resistance to rubidazone (NSC-164011) in Ehrlich ascites tumor in vivo.
    Skovsgaard T
    Cancer Chemother Rep; 1975; 59(2 Pt 1):301-8. PubMed ID: 1149008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
    Tong GL; Cory M; Lee WW; Henry DW
    J Med Chem; 1978 Aug; 21(8):732-7. PubMed ID: 690999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action].
    Povarov LS; Gol'dberg LE; Bazhanov VS; Olsuf'eva EN; Averbukh LA
    Antibiotiki; 1981 Nov; 26(11):813-6. PubMed ID: 6895688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute cardiovascular alterations induced by low doses of adriamycin, rubidazone, and daunorubicin in the anesthetized beagle dog.
    Herman EH; Young RS
    Cancer Treat Rep; 1979; 63(11-12):1771-9. PubMed ID: 526912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumors.
    Kovach JS; Ames MM; Sternad ML; O'Connell MJ
    Cancer Res; 1979 Mar; 39(3):823-8. PubMed ID: 427770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Benjamin RS; Mason JW; Billingham ME
    Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor antibiotic carminomycin.
    Gause GF
    Z Allg Mikrobiol; 1980; 20(3):219-25. PubMed ID: 6158803
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group study.
    Smith FE; Gad-el-Mawla N; Tranum B; Baker LH; Panettiere FJ; Athens JW; Foulkes M
    Invest New Drugs; 1983; 1(4):315-9. PubMed ID: 6678878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced toxicity of daunorubicin by conjugation to dextran.
    Levi-Schaffer F; Bernstein A; Meshorer A; Arnon R
    Cancer Treat Rep; 1982 Jan; 66(1):107-14. PubMed ID: 6171348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.